Fig. 7. (A) Cell cycle analysis of BEAS cells treated with a high concentration of AFDC (800 μg mL–1) for 36 h and 72 h. (B) Western blot analysis of caspase-9, caspase-8, caspase-3 and PARP expression in BEAS-2B cells treated with AFDC (1000 μg mL–1). (C) Caspase-3/7 activity of BEAS cells treated with a high concentration of AFDC (1000 μg mL–1) with or without the caspase-8 inhibitor for 24, 36, 48, and 72 h.
